In my view, it's silly using plain technical analysis on Healthscope's share price in the current circumstances. They have had a recent institutional raising at $2.58 per share and this would have pulled the share price down, other things being equal.
In my view, it's silly using plain technical analysis on...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)